The Journal of Pain
Volume 10, Issue 10 , Pages 1038-1050 , October 2009

Comparative Cognitive and Subjective Side Effects of Immediate-Release Oxycodone in Healthy Middle-Aged and Older Adults

  • Monique M. Cherrier

      Affiliations

    • Department of Psychiatry, School of Medicine, University of Washington, Seattle, Washington
    • Veterans Administration Puget Sound Health Care System, Mental Illness Research, Education, and Clinical Center, Seattle, Washington
    • Corresponding Author InformationAddress reprint requests to M. Cherrier, GRECC 182B VAPSHCS, 1660 S. Columbian Way, Seattle, WA, 98108.
    • ,
  • John K. Amory

      Affiliations

    • Department of Medicine, School of Medicine, University of Washington, Seattle, Washington
    • ,
  • Mary Ersek

      Affiliations

    • School of Nursing, University of Pennsylvania, Philadelphia, Pennsylvania
    • ,
  • Linda Risler

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington
    • ,
  • Danny D. Shen

      Affiliations

    • Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, Washington

Received 11 November 2008 ,Revised 23 March 2009 ,Accepted 25 March 2009.

References 

  1. Alladi S, Arnold R, Mitchell J, Nestor PJ, Hodges JR. Mild cognitive impairment: Applicability of research criteria in a memory clinic and characterization of cognitive profile. Psychol Med. 2006;36:507–515
  2. American Geriatrics Society . The management of persistent pain in older persons. J Am Geriatr Soc. 2002;50:S205–S224
  3. American Pain Society (ed) Guideline for the Management of Pain in Osteoarthritis . Rheumatoid Arthritis and Juvenile Chronic Arthritis. Glenview, IL: American Pain Society; 2002;
  4. Andersson C, Lindau M, Almkvist O, Engfeldt P, Johansson SE, Eriksdotter Jonhagen M. Identifying patients at high and low risk of cognitive decline using Rey Auditory Verbal Learning Test among middle-aged memory clinic outpatients. Dement Geriatr Cogn Disord. 2006;21:251–259
  5. Balthazar ML, Martinelli JE, Cendes F, Damasceno BP. Lexical semantic memory in amnestic mild cognitive impairment and mild Alzheimer's disease. Arq Neuropsiquiatr. 2007;65:619–622
  6. Bates ME, Lemay EP. The d2 Test of attention: construct validity and extensions in scoring techniques. J Int Neuropsychol Soc. 2004;10:392–400
  7. Benedict RHB, Schretlen D, Groninger L, Brandt J. Hopkins Verbal Learning Test–Revised: Normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol. 1998;12:43–55
  8. Black ML, Hill JL, Zacny JP. Behavioral and physiological effects of remifentanil and alfentanil in healthy volunteers. Anesthesiology. 1999;90:718–726
  9. Blyth F, March L, Brnabic A, Jorm L, Williamson M, Cousins M. Chronic pain in Australia: A prevalence study. Pain. 2001;89:127–134
  10. Brandt J. The Hopkins verbal learning test: development of a new memory test with six equivalent forms. Clin Neuropsychologist. 1991;5:125–142
  11. Brickenkamp R, Zillmer E. The d2 Test of Attention. Seattle, WA: Hogrefe & Huber; 1998;
  12. Bruera E, Macmillan K, Hanson J, MacDonald RN. The cognitive effects of the administration of narcotic analgesics in patients with cancer pain. Pain. 1989;39:13–16
  13. Buckalew N, Haut MW, Morrow L, Weiner D. Chronic pain is associated with brain volume loss in older adults: Preliminary evidence. Pain Med. 2008;9:240–248
  14. Carmaciu C, Iliffe S, Kharicha K, Harari D, Swift C, Gillmann G, et al. Health risk appraisal in older people 3: Prevalence, impact, and context of pain and their implications for GPs. Br J Gen Pract. 2007;57:630–635
  15. Cherrier MM, Matsumoto AM, Amory JK, Johnson M, Craft S, Peskind ER, et al. Characterization of verbal and spatial memory changes from moderate to supraphysiological increases in serum testosterone in healthy older men. Psychoneuroendocrinology. 2007;32:72–79
  16. Coda BA, Brown MC, Risler L, Syrjala K, Shen DD. Equivalent analgesia and side effects during epidural and pharmacokinetically tailored intravenous infusion with matching plasma alfentanil concentration. Anesthesiology. 1999;90:98–108
  17. Dagtekin O, Gerbershagen HJ, Wagner W, Petzke F, Radbruch L, Sabatowski R. Assessing cognitive and psychomotor performance under long-term treatment with transdermal buprenorphine in chronic noncancer pain patients. Anesth Analg. 2007;105:1442–1448
  18. Davis KL, Price CC, Kaplan E, Libon DJ. Error analysis of the nine-word California Verbal Learning Test (CVLT-9) among older adults with and without dementia. Clin Neuropsychol. 2002;16:81–89
  19. Donald IP, Foy C. A longitudinal study of joint pain in older people. Rheumatology (Oxford). 2004;43:1256–1260
  20. Dworkin SF, Von Korff M, Whitney CW, Le Resche L, Bicker BG, Barlow W. Measurement of characteristic pain intensity in field research. Pain:S290. 1990;
  21. Elliott AM, Smith BH, Penny KI, Smith WC, Chambers WA. The epidemiology of chronic pain in the community. Lancet. 1999;354:1248–1252
  22. Elliott AM, Smith BH, Smith WC, Chambers WA. Changes in chronic pain severity over time: The chronic pain grade as a valid measure. Pain. 2000;88:303–308
  23. Erjavec MK, Coda BA, Nguyen Q, Donaldson G, Risler L, Shen DD. Morphine-fluoxetine interactions in healthy volunteers: Analgesia and side effects. J Clin Pharmacol. 2000;40:1286–1295
  24. Ersek M, Cherrier MM, Overman S, Irving GA. Cognitive effects of opioids. Pain Manag Nurs. 2004;5:75–93
  25. Ersek M, Kraybill BM, Du Pen A. Factors hindering patients' use of medications for cancer pain. Cancer Practice. 1999;7:226–232
  26. Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA. 2004;291:2959–2968
  27. Farrell MJ, Gibson SJ, Helme RD. Chronic nonmalignant pain in older people. In:  Ferrell BR,  Ferrell BA editor. Pain in the Elderly. Seattle, WA: IASP Press; 1996;
  28. Frank RM, Bryne GJ. The clinical utility of the Hopkins Verbal Learning Test as a screening test for mild dementia. Int J Geriatr Psychiatry. 2000;15:317–324
  29. Gaertner J, Radbruch L, Giesecke T, Gerbershagen H, Petzke F, Ostgathe C, et al. Assessing cognition and psychomotor function under long-term treatment with controlled release oxycodone in non-cancer pain patients. Acta Anaesthesiol Scand. 2006;50:664–672
  30. Gagliese L, Melzack R. Chronic pain in elderly people. Pain. 1997;70:3–14
  31. Gerard L, Zacks RT, Hasher L, Radvansky GA. Age deficits in retrieval: The fan effect. J Gerontol. 1991;46:P131–P136
  32. Hanks GW, O'Neill WM, Simpson P, Wesnes K. The cognitive and psychomotor effects of opioid analgesics. II. A randomized controlled trial of single doses of morphine, lorazepam and placebo in healthy subjects. Eur J Clin Pharmacol. 1995;48:455–460
  33. Herr K, Spratt K, Mobily P, Richardson G. Pain intensity assessemnt in older adults: Use of experimental pain to compare psychometric properties and usability of selected pain scales with younger adults. Clin J Pain. 2004;20:207–219
  34. Hinton Bayre AD, Geffen G, McFarland K. Mild head injury and speed of information processing: A prospective study of professional rugby league players. J Clin Exp Neuropsychol. 1997;19:275–289
  35. Horsfield SA, Rosse RB, Tomasino V, Schwartz BL, Mastropaolo J, Deutsch SI. Fluoxetine's effects on cognitive performance in patients with traumatic brain injury. Int J Psychiatry Med. 2002;32:337–344
  36. Jamison RN, Schein JR, Vallow S, Ascher S, Vorsanger GJ, Katz NP. Neuropsychological effects of long-term opioid use in chronic pain patients. J Pain Symptom Manage. 2003;26:913–921
  37. Jensen MP, Turner JA, Romano JM, Fisher LD. Comparative reliability and validity of chronic pain intensity measures. Pain. 1999;83:157–162
  38. Jones TG, Schinka JA, Vanderploeg RD, Small BJ, Graves AB, Mortimer JA. 3MS normative data for the elderly. Arch Clin Neuropsychol. 2002;17:171–177
  39. Kaiko RF, Benziger DP, Fitzmartin RD, Burke BE, Reder RF, Goldenheim PD. Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone. Clin Pharmacol Ther. 1996;59:52–61
  40. Kamboj SK, Tookman A, Jones L, Curran HV. The effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative care. Pain. 2005;117:388–395
  41. Karp JF, Reynolds CF, Butters MA, Dew MA, Mazumdar S, Begley AE, et al. The relationship between pain and mental flexibility in older adult pain clinic patients. Pain Med. 2006;7:444–452
  42. Kokubun H, Fukawa M, Matoba M, Hoka S, Yamada Y, Yago K. Pharmacokinetics and variation in the clearance of oxycodone and hydrocotarnine in patients with cancer pain. Biol Pharm Bull. 2007;30:2173–2177
  43. Konat GW, Kraszpulski M, James I, Zhang HT, Abraham J. Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats. Metab Brain Dis. 2008;23:325–333
  44. Lalovic B, Kharasch E, Hoffer C, Risler L, Liu-Chen LY, Shen DD. Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: Role of circulating active metabolites. Clin Pharmacol Ther. 2006;79:461–479
  45. Lawlor PG. The panorama of opioid-related cognitive dysfunction in patients with cancer: A critical literature appraisal. Cancer. 2002;94:1836–1853
  46. Lin JJ, Alfandre D, Moore C. Physician attitudes toward opioid prescribing for patients with persistent noncancer pain. Clin J Pain. 2007;23:799–803
  47. Liukas A, Kuusniemi K, Aantaa R, Virolainen P, Neuvonen M, Neuvonen P, et al. Plasma concentrations of oral oxycodone are greatly increased in the elderly. Clin Pharmacol Ther. 2008;84:462–467
  48. Menefee LA, Frank ED, Crerand C, Jalali S, Park J, Sanschagrin K, et al. The effects of transdermal fentanyl on driving, cognitive performance, and balance in patients with chronic nonmalignant pain conditions. Pain Med. 2004;5:42–49
  49. Mitrushina M, Satz P, Chervinsky A, D'Elia L. Performance of four age groups of normal elderly on the Rey Auditory-Verbal Learning Test. J Clin Psychol. 1991;47:351–357
  50. Mobily PR, Herr KA, Clark MK, Wallace RB. An epidemiologic analysis of pain in the elderly: The Iowa 65+ Rural Health Study. J Aging Health. 1994;6:139–145
  51. Morgan SF, Wheelock J. Comparability of WAIS–R digit symbol and the Symbol Digit Modalities Test. Percept Mot Skills. 1995;80:631–634
  52. Multhaup KS, Balota DA, Faust ME. Exploring semantic memory by investigating buildup and release of proactive interference in healthy older adults and individuals with dementia of the Alzheimer type. J Int Neuropsychol Soc. 2003;9:830–838
  53. Nelson CJ, Nandy N, Roth AJ. Chemotherapy and cognitive deficits: Mechanisms, findings, and potential interventions. Palliative & supportive care. 2007;5:273–280
  54. O'Neill WM, Hanks GW, Simpson P, Fallon MT, Jenkins E, Wesnes K. The cognitive and psychomotor effects of morphine in healthy subjects: A randomized controlled trial of repeated (four) oral doses of dextropropoxyphene, morphine, lorazepam and placebo. Pain. 2000;85:209–215
  55. Pascualy M, Petrie EC, Brodkin K, Peskind ER, Veith RC, Raskind MA. Effects of advanced aging on plasma catecholamine responses to the cold pressor test. Neurobiol Aging. 1999;20:637–642
  56. Pascualy M, Petrie EC, Brodkin K, Peskind ER, Wilkinson CW, Raskind MA. Hypothalamic pituitary adrenocortical and sympathetic nervous system responses to the cold pressor test in Alzheimer's disease. Biol Psychiatry. 2000;48:247–254
  57. Penny KI, Purves AM, Smith BH, Chambers WA, Smith WC. Relationship between the chronic pain grade and measures of physical, social and psychological well-being. Pain. 1999;79:275–279
  58. Petersen A, Lantz M. Evaluating the ability to live safely at home: Role of neuropsychological testing. Clin Geriatr. 2002;10:28–31
  59. Preston KL, Bigelow GE, Liebson IA. Antagonist effects of nalbuphine in opioid-dependent human volunteers. J Pharmacol Exp Ther. 1989;248:929–937
  60. Rasmusson DX, Bylsma FW, Brandt J. Stability of performance on the Hopkins Verbal Learning Test. Arch Clin Neuropsychol. 1995;10:21–26
  61. Riley WT, Mabe PA, Schear JM. A brief neuropsychological screening battery to detect brain damage in a psychiatric population. J Psychopathol Behav Assess. 1987;9:67–74
  62. Schindler SD, Ortner R, Peternell A, Eder H, Opgenoorth E, Fischer G. Maintenance therapy with synthetic opioids and driving aptitude. Eur Addict Res. 2004;10:80–87
  63. Schoenberg MR, Dawson KA, Duff K, Patton D, Scott JG, Adams RL. Test performance and classification statistics for the Rey Auditory Verbal Learning Test in selected clinical samples. Arch Clin Neuropsychol. 2006;21:693–703
  64. Scudds RJ, Robertson JM. Pain factors associated with physical disability in a sample of community-dwelling senior citizens. J Gerontol A Biol Sci Med Sci. 2000;55:M393–M399
  65. Shapiro AM, Benedict RH, Schretlen D, Brandt J. Construct and concurrent validity of the Hopkins Verbal Learning Test-revised. Clin Neuropsychol. 1999;13:348–358
  66. Sjogren P, Olsen AK, Thomsen AB, Dalberg J. Neuropsychological performance in cancer patients: The role of oral opioids, pain and performance status. Pain. 2000;86:237–245
  67. Sjogren P, Thomsen AB, Olsen AK. Impaired neuropsychological performance in chronic nonmalignant pain patients receiving long-term oral opioid therapy. J Pain Symptom Manage. 2000;19:100–108
  68. Smith BH, Penny KI, Purves AM, Munro C, Wilson B, Grimshaw J, et al. The Chronic Pain Grade questionnaire: Validation and reliability in postal research. Pain. 1997;71:141–147
  69. Steffens DC, Norton MC, Plassman BL, Tschanz JT, Wyse BW, Welsh-Bohmer KA, et al. Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women. J Am Geriatr Soc. 1999;47:1171–1175
  70. Strain EC, Preston KL, Liebson IA, Bigelow GE. Precipitated withdrawal by pentazocine in methadone-maintained volunteers. J Pharmacol Exp Ther. 1993;267:624–634
  71. Tassain V. Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain. Pain. 2003;104:389–400
  72. Thomas E, Peat G, Harris L, Wilkie R, Croft PR. The prevalance of pain and pain interference in a general population of older adults: Cross-sectional findings from the North Staffordshire Osteoarthritis Project (NorStop). Pain. 2004;110:361–368
  73. Thomason TE, McCune JS, Bernard SA, Winer EP, Tremont S, Lindley CM. Cancer pain survey: Patient-centered issues in control. J Pain Symptom Manage. 1998;15:275–284
  74. Uchiyama CL, D'Elia LF, Dellinger AM, Selnes OA. Longitudinal comparison of alternate versions of the symbol digit modalities test: Issues of form comparability and moderating demographic variables. Clin Neuropsychol. 1994;8:209–218
  75. Vanderploeg RD, Schinka JA, Jones T, Small BJ, Graves AB, Mortimer JA. Elderly norms for the Hopkins Verbal Learning Test–Revised. Clin Neuropsychol. 2000;14:318–324
  76. Villesen HH, Banning AM, Petersen RH, Weinelt S, Poulsen JB, Hansen SH, et al. Pharmacokinetics of morphine and oxycodone following intravenous administration in elderly patients. Ther Clin Risk Manag. 2007;3:961–967
  77. Von Korff M, Dworkin SF, Le Resche L. Graded chronic pain status: an epidemiologic evaluation. Pain. 1990;40:279–291
  78. Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain. 1992;50:133–149
  79. Walker DJ, Zacny JP. Subjective, psychomotor, and analgesic effects of oral codeine and morphine in healthy volunteers. Psychopharmacology (Berl). 1998;140:191–201
  80. Walker DJ, Zacny JP. Subjective, psychomotor, and physiological effects of cumulative doses of opioid mu agonists in healthy volunteers. J Pharmacol Exp Ther. 1999;289:1454–1464
  81. Walker DJ, Zacny JP, Galva KE, Lichtor JL. Subjective, psychomotor, and physiological effects of cumulative doses of mixed-action opioids in healthy volunteers. Psychopharmacology. 2001;155:362–371
  82. Washington LL, Gibson SJ, Helme RD. Age-related differences in the endogenous analgesic response to repeated cold water immersion in human volunteers. Pain. 2000;89:89–96
  83. Wechsler D. Wechsler Memory Scale III. San Antonio, TX: The Psychological Corporation; 1997;
  84. Weiner DK, Hanlon JT, Studenski SA. Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly. Gerontology. 1998;44:217–221
  85. Weiner DK, Rudy TE, Morrow L, Slaboda J, Lieber S. The relationship between pain, neuropsychological performance, and physical function in community-dwelling older adults with chronic low back pain. Pain Med. 2006;7:60–70
  86. Zacny J. A review of the effects of opioids on psychomotor and cognitive functioning in humans. Exp Clin Psychoparm. 1995;3:432–466
  87. Zacny JP. Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan) in non-drug-abusing volunteers. Psychopharmacology. 2003;165:146–156
  88. Zacny JP, Conley K, Galinkin J. Comparing the subjective, psychomotor and physiological effects of intravenous buprenorphine and morphine in healthy volunteers. J Pharmacol Exp Ther. 1997;282:1187–1197
  89. Zacny JP, Conley K, Marks S. Comparing the subjective, psychomotor and physiological effects of intravenous nalbuphine and morphine in healthy volunteers. J Pharmacol Exp Ther. 1997;280:1159–1169
  90. Zacny JP, Hill JL, Black ML, Sadeghi P. Comparing the subjective, psychomotor and physiological effects of intravenous pentazocine and morphine in normal volunteers. J Pharmacol Exp Ther. 1998;286:1197–1207
  91. Zacny JP, Lichtor JL, Flemming D, Coalson DW, Thompson WK. A dose-response analysis of the subjective, psychomotor and physiological effects of intravenous morphine in healthy volunteers. J Pharmacol Exp Ther. 1994;268:1–9
  92. Zacny JP, Lichtor JL, Klafta JM, Alessi R, Apfelbaum JL. The effects of transnasal butorphanol on mood and psychomotor functioning in healthy volunteers. Anesth Analg. 1996;82:931–935
  93. Zacny JP, Lichtor JL, Thapar P, Coalson DW, Flemming D, Thompson WK. Comparing the subjective, psychomotor and physiological effects of intravenous butorphanol and morphine in healthy volunteers. J Pharmacol Exp Ther. 1994;270:579–588

 Supported in part by NIA R21 025503 and M01-RR-00037.

PII: S1526-5900(09)00476-3

doi: 10.1016/j.jpain.2009.03.017

The Journal of Pain
Volume 10, Issue 10 , Pages 1038-1050 , October 2009

Article Tools

* Image Usage & Resolution